Tanhaji, Maina H.
HRN: 22-81-27 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/30/2023
AMPICILLIN 1GM (VIAL)
03/30/2023
03/31/2023
IV
2g
Q6h
Leukocytosis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes